{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["STANFORD UNIVERSITY"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1222003"],"scientific_name":["Homo sapiens"],"long_description":["SU2C-SARC032 was a phase II international, randomized trial for patients with localized, high-risk undifferentiated pleomorphic sarcoma or dedifferentiated or pleomorphic liposarcoma of the extremity and limb girdle. On the trial, the addition of perioperative pembrolizumab to preoperative radiotherapy and surgery improved disease-free survival compared to preoperative radiotherapy and surgery alone. Bulk RNA-sequencing was performed on pre-treatment and surgically resected tumor specimens."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Non-invasive characterization of human soft tissue sarcoma response to radiation therapy","description":"Non-invasive characterization of human soft tissue sarcoma response to radiation therapy","dates":{"last_updated":"2025-09-24","first_public":"2025-09-08"},"accession":"PRJNA1222003","cross_references":{"taxon":["9606"]}}